Drugs / E7107
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00499499 | Jul 2007 → Jun 2009 | cancer | Eisai Inc. | Suspended | No outcome recorded |
| Phase 1 | NCT00459823 | May 2007 → Jun 2009 | cancer | Eisai Inc. | Suspended | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E7107 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00499499 ↗ |
| Action | Inhibit | “a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor” PMID 24258465 ↗ Nov 2013 |
| Modality | Small molecule | — CHEMBL4297278 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT00459823 ↗ |